Danny Yeh joined Genentech in 2016 and has held various leadership roles under US Medical Affairs. Currently, he is the head of Health Policy and Systems Research, a team that conducts health services research designed to inform US health care policies aimed at reducing inefficiencies, improving quality, and enabling patient access. Prior to Genentech, Danny held different roles in Health Economics & Outcomes Research function at Biogen and Allergan. Danny holds a B.S. in Pharmacy from National Taiwan University, an M.S. degree in Pharmaceutical Economics, Policy, and Outcomes Research from the University of Arizona, and a Ph.D. in Health Policy and Management from the University of North Carolina at Chapel Hill.